Senior insider sale
TAYSHA GENE THERAPIES, INC. — senior position signals high conviction
$2.45M
570.17K shares
What this filing means
NAGENDRAN SUKUMAR plans to sell 570.17K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $2.45M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/28/2025ACC: 0001974158-25-000077
Director
Since Sep 2020
570.17K
Shares to sell
$2.45M
Approx. market value
370.17K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Vested Stock Option Grant
N/A
1/2/2024
300KVested Stock Option Grant
N/A
5/31/2023
70.17KTotal acquired370.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2024 | Vested Stock Option Grant N/A | 300K | — |
5/31/2023 | Vested Stock Option Grant N/A | 70.17K | — |
| Total | 370.17K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
200K
Market value
$646.2K
9/10/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
370.17K
Market value
$1.80M
11/28/2025
Total
Units
570.17K
Value
$2.45M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/10/2025 | 200K | $646.2K | — | Completed |
| Planned — Approximate Date | ||||
11/28/2025 | 370.17K | $1.80M | Nasdaq | Planned |
| Total | 570.17K | $2.45M | ||